{"transactions":[{"id":2992415,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":145535,"kind":"person","name":"Christgau Stephan","position":1,"cik":"0001360578","reported_name":"Christgau Stephan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Preferred Stock","published_at":"2020-11-04T20:00:09.000Z","date":"2020-11-02","kind":"exercise","acquired":false,"shares":184433,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series D Preferred Stock (the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock at a ratio of 2.59970:1 upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series D Preferred Stock (the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock at a ratio of 2.59970:1 upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series D Preferred Stock (the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock at a ratio of 2.59970:1 upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Eir Ventures I AB (\"Eir Ventures\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a founding partner of Eir Ventures Partners AB, the General Partner/Manager of Eir Ventures, and shares voting and dispositive power with respect to the shares held by Eir Ventures. Dr. Christgau disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":479470},"source":{"system":"sec-edgar","filing":"0000899243-20-030410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1360578/000089924320030410/doc4.xml","form_type":"4"}},{"id":2992414,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":145535,"kind":"person","name":"Christgau Stephan","position":1,"cik":"0001360578","reported_name":"Christgau Stephan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-04T20:00:09.000Z","date":"2020-11-02","kind":"purchase","acquired":true,"shares":66666,"price":15,"value":999990.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Eir Ventures I AB (\"Eir Ventures\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a founding partner of Eir Ventures Partners AB, the General Partner/Manager of Eir Ventures, and shares voting and dispositive power with respect to the shares held by Eir Ventures. Dr. Christgau disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein."}],"balance_after":546136,"source":{"system":"sec-edgar","filing":"0000899243-20-030410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1360578/000089924320030410/doc4.xml","form_type":"4"}},{"id":2992413,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":145535,"kind":"person","name":"Christgau Stephan","position":1,"cik":"0001360578","reported_name":"Christgau Stephan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-04T20:00:09.000Z","date":"2020-11-02","kind":"exercise","acquired":true,"shares":479470,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series D Preferred Stock (the \"Preferred Stock\") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock at a ratio of 2.59970:1 upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Eir Ventures I AB (\"Eir Ventures\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a founding partner of Eir Ventures Partners AB, the General Partner/Manager of Eir Ventures, and shares voting and dispositive power with respect to the shares held by Eir Ventures. Dr. Christgau disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein."}],"balance_after":479470,"source":{"system":"sec-edgar","filing":"0000899243-20-030410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1360578/000089924320030410/doc4.xml","form_type":"4"}}]}